Humacyte, Inc.
Ticker: 1818382
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2021 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.75+150.0% | 0.30-42.3% | 0.52+116.7% | 0.24 |
| Total Income | 0.75+150.0% | 0.30-42.3% | 0.52+116.7% | 0.24 |
| EXPENSES | ||||
| Expenditure | 25.14-16.3% | 30.03+26.7% | 23.70+14.1% | 20.78 |
| Tax | 0.00 | 0.00 | 0.00 | — |
| PROFIT | ||||
| Net Profit | -17.51+53.5% | -37.66-196.2% | 39.14+224.0% | -31.56 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00% |
| EPS | -0.11+54.2% | -0.24-185.7% | 0.28+138.9% | -0.72 |
Corporate Events
Board MeetingHUMA
20269Jun
Board Meeting
Results of the 2026 Annual Meeting of Stockholders, includin…
SEC Filing ↗ Board MeetingHUMA
202612May
Board Meeting
Appointment of Todd E. Rasmussen, M.D., as Chief Surgical Of…
SEC Filing ↗